Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCTV01E-MRCT-1
PACTR202204735722575Phase 3Not yet recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Apr 2022
- Modality
- Vaccines & Immunotherapeutics, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of SCTV01E, BBIBP-CorV and coronavac in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Sinocelltech Group Limited. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
SCTV01EBBIBP-CorVcoronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202204735722575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202204735722575.